Skip to main content
Biohit Oyj logo

Biohit Oyj — Investor Relations & Filings

Ticker · BIOBV ISIN · FI0009005482 LEI · 74370089ATTSNBXJVT29 HE Manufacturing
Open in API
Filings indexed 992 across all filing types
Latest filing 2023-05-24 AGM Information
Country FI Finland
Listing HE BIOBV

About Biohit Oyj

https://www.biohithealthcare.com/en/

Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.

Recent filings

Filing Released Lang Actions
Biohit Oyj:n yhtiökokouskutsu
AGM Information Classification · 100% confidence The document title is "Biohit Oyj:n yhtiökokouskutsu" which translates to "Biohit Oyj: Notice of Annual General Meeting". The text details the date, time, and location of a general meeting (14.6.2023), lists the agenda items (including presentation of the 2022 financial statements, election of board members, and dividend proposals), and provides instructions for shareholder registration and proxy voting. These elements are characteristic of a formal notice calling shareholders to an Annual General Meeting (AGM). This aligns perfectly with the definition for AGM Information (AGM-R).
2023-05-24 Finnish
03290850.pdf
Share Issue/Capital Change Classification · 100% confidence The document is a stock exchange release from Biohit Oyj announcing the subscription of new B-series shares through option rights (I 2021A and I 2022A). It details the number of new shares issued, the subscription price, the registration date, and the resulting change in the total number of shares. This falls under the category of share issues or capital changes.
2023-03-30 Finnish
Biohit Oyj:n B-osakkeiden merkintä optio-oikeuksilla I 2021A ja I 2022A
Share Issue/Capital Change Classification · 100% confidence The document announces the issuance of new B-shares resulting from the exercise of stock options (I 2021A and I 2022A). It details the number of new shares, the subscription price, the registration date, and the impact on the total number of shares. This falls under the category of share issuance or capital changes.
2023-03-30 Finnish
Biohit Oyj B-shares Subscribed with Stock Options I 2021A and I 2022A
Share Issue/Capital Change Classification · 98% confidence The document is a 'Stock Exchange Release' from Biohit Oyj announcing that new B-shares were subscribed for using stock options (I 2021A and I 2022A). It details the number of shares issued (68,000), the subscription price (EUR 1.00), the resulting total number of shares, and the effective dates for registration and trading. This activity directly relates to changes in the company's share capital structure resulting from the exercise of employee/option schemes. This fits best under the 'Share Issue/Capital Change' category (SHA), as it details the issuance of new shares and the resulting capital structure update, rather than just a general financing announcement (CAP) or a transaction in own shares (POS, which usually implies buybacks/treasury stock transactions).
2023-03-30 English
Biohit Oyj:n B-osakkeiden merkintä optio-oikeuksilla I 2021A ja I 2022A
Share Issue/Capital Change Classification · 98% confidence The document is a 'Pörssitiedote' (Stock Exchange Release) dated March 30, 2023, detailing the subscription of new B-shares using option rights (I 2021A and I 2022A). It specifies the number of shares issued (68,000), the subscription price (€1.00), the resulting total number of shares, and the registration date. This announcement directly concerns a change in the company's capital structure due to the exercise of employee/shareholder options, which results in an increase in the total number of shares outstanding. This aligns precisely with the definition of 'Share Issue/Capital Change' (SHA). Although it involves options, the core event being reported is the resulting share issuance and capital structure update, not just the option program terms.
2023-03-30 Finnish
03226608.pdf
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction in shares by a company executive (CFO Jussi Sorvo). It includes specific details such as the person's name, position, transaction date, instrument type, and volume. This aligns perfectly with the definition of a Director's Dealing (DIRS) filing, which covers personal share transactions by company directors and executives.
2023-03-23 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.